Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.002
Sell
RSI(14)
51.627
Neutral
STOCH(KDJ)(9,3,3)
60.659
Buy
ATR(14)
0.015
High Vlolatility
CCI(14)
21.767
Neutral
Williams %R
23.000
Buy
TRIX(12,20)
-0.297
Sell
StochRSI(14)
91.575
Buy
SeaStar Medical Holding Corp
ICUCWView Detailed Chart
0.038USD
+0.005+18.46%
Close 04/23, 16:00（ET）Quotes delayed by 15 min
0.00Market Cap
--P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+18.46%
5 Days
-7.23%
1 Month
-16.30%
6 Months
+1.85%
Year to Date
+86.89%
1 Year
-60.75%
View Detailed Chart
Agency Rating
No Data
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Buy
Moving Average
Indicators
Value
Direction
MA5
0.030
Buy
MA10
0.037
Buy
MA20
0.036
Buy
MA50
0.034
Buy
MA100
0.032
Buy
MA200
0.044
Sell
News
More news coming soon, stay tuned...
Company
SeaStar Medical Holding Corporation is a commercial-stage medical technology company, which is focused on transforming treatments for critically ill patients facing organ failure and potential loss of life. The Company’s Selective Cytopheretic Device (SCD) is designed as a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation and creates a cascade of events that wreak havoc in the patient’s body. It has broad potential applications for patients suffering from both acute and chronic kidney disease as well as cardiovascular and other serious inflammatory diseases. Its SCD therapy is an extracorporeal synthetic membrane device designed to bind activated leukocytes (neutrophils and monocytes) when integrated into an existing continuous renal replacement therapy (CRRT) circuit in conjunction with the use of regional citrate anticoagulation (RCA).
Company codeICUCW
CompanySeaStar Medical Holding Corp
CEOMr. Eric Schlorff
Websitehttps://seastarmedical.com
